BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for Stem Cells / HSCs

Hematopoietic Stem Cells (HSCs)

Stem Cell Clinical Trials – How to Find One for Your Condition?

By 1 Comment

Stem cell clinical trials are research studies that involves human patients. Learn a simple tool to identify stem cell clinical trials for your condition.

Are you or a loved on suffering from arthritis, multiple sclerosis (MS), Alzheimer’s disease, dementia, or other chronic condition? If so, how do you find a stem cell clinical trial? This is a question that we get asked on a regular basis by readers of our site.

This article provides all the answers, including links to global registries to find a trial within your region and direct links to clinical trials by condition.

Use this guide to get started with your search for a stem cell clinical trial near you.

[Read more…]

Could NiCord® by Gamida Cell Introduce a Paradigm Shift to HSCT?

By

Gamida CellGamida Cell is an Israeli company specializing in cellular and immune therapies for the treatment of cancer and orphan genetic diseases. The company is developing a diverse clinical pipeline based on its proprietary NAM technology platform. It lead program, NiCord®, is now in Phase 3 development for allogeneic bone marrow transplantation.

NiCord® was granted Breakthrough Therapy Designation by the FDA, as well orphan drug designation by the European Medicines Agency (EMA). [Read more…]

Cord Blood Industry Trends – Clinical Trials, Publications, Patents, Grants, & More

By

With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends. There are now fewer market players, because numerous small cord blood banks have either been acquired or gone out of business.

However, this era of maturation and consolidation has had as many benefits to surviving cord blood banks as drawbacks. On average, the remaining market participants are now larger, stronger, better capitalized, and storing larger quantities of cord blood and tissue units than when the market was more fragmented.

[Read more…]

The Market for Cord Blood and Tissue Banking in China

By

China has a fascinating and unique market for cord blood banking. First, the Chinese government only allows one cord blood bank in each of the Chinese provinces. The Chinese government issues one cord blood banking license per province, and the licensed company must function as both a public (donation-based) and private (for-profit) bank. The for-profit division funds the company’s donation-based public division, because no government support is received for this purpose. [Read more…]

BioInformant's World-Class Clients